SecBot SecBot
SECBOTREPLAY Home › Report › PRCT

PRCT · Q3 revenue +18% YoY

PROCEPT BioRobotics Corp · 8-K filed Nov 4, 2026 at 16:18 ET

At the news

NEUTRALIMPACT 5/10

8-K filed Nov 4, 2026 at 16:18 ET

The company reaffirmed its full-year 2026 revenue guidance of $390M-$410M and its adjusted EBITDA loss guidance of $35M-$30M, while U.S. procedure growth of 22% and handpiece ASP increases of 12% showed positive operational trends.

  • Q3 2026 total revenue $98.3M, up 18% YoY from $83.3M
  • U.S. procedures over 13,400, up approximately 22% YoY
  • U.S. handpiece ASP approximately $3,570, up 12% YoY
  • International revenue $12.5M, up 32% YoY

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access